Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) has shared an update.
Epsilon Healthcare Limited reported significant revenue growth and improved financial performance for the quarter ending June 2025, marking a pivotal point in its recovery and growth trajectory. The company has seen substantial growth in contract manufacturing activities, a successful launch of its pharmacy operations, and consistent performance from its clinics, positioning it for sustained growth and long-term value creation.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited operates in the healthcare industry, focusing on contract manufacturing through its Epsilon Pharma CDMO subsidiary, pharmacy operations, and clinics. The company is dedicated to building a resilient and scalable healthcare business, with a strong emphasis on quality, reliability, and patient care.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
For detailed information about EPN stock, go to TipRanks’ Stock Analysis page.